Processa Pharmaceuticals, Inc. (PCSA) income statement
PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.56−0.13 (-7.69%)
Close on Nov 20, 2026Market cap $4.36MP/E –Yield –
Processa Pharmaceuticals, Inc. financial ratios
See a number that looks wrong?